SE447449B - Farmaceutisk komposition innehallande cytidindifosfokolin och vegetabiliska fosfolipider - Google Patents

Farmaceutisk komposition innehallande cytidindifosfokolin och vegetabiliska fosfolipider

Info

Publication number
SE447449B
SE447449B SE8102456A SE8102456A SE447449B SE 447449 B SE447449 B SE 447449B SE 8102456 A SE8102456 A SE 8102456A SE 8102456 A SE8102456 A SE 8102456A SE 447449 B SE447449 B SE 447449B
Authority
SE
Sweden
Prior art keywords
choline
cdp
pharmaceutical composition
uci
phospholipids
Prior art date
Application number
SE8102456A
Other languages
English (en)
Swedish (sv)
Other versions
SE8102456L (sv
Inventor
E Borgo
Original Assignee
Made Italiana Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Italiana Srl filed Critical Made Italiana Srl
Publication of SE8102456L publication Critical patent/SE8102456L/xx
Publication of SE447449B publication Critical patent/SE447449B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8102456A 1980-04-18 1981-04-15 Farmaceutisk komposition innehallande cytidindifosfokolin och vegetabiliska fosfolipider SE447449B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8048454A IT1207106B (it) 1980-04-18 1980-04-18 Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Publications (2)

Publication Number Publication Date
SE8102456L SE8102456L (sv) 1981-10-19
SE447449B true SE447449B (sv) 1986-11-17

Family

ID=11266633

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8102456A SE447449B (sv) 1980-04-18 1981-04-15 Farmaceutisk komposition innehallande cytidindifosfokolin och vegetabiliska fosfolipider

Country Status (15)

Country Link
US (1) US4386077A (fr)
AT (1) AT376366B (fr)
AU (1) AU544469B2 (fr)
BE (1) BE890796A (fr)
CH (1) CH652026A5 (fr)
DE (1) DE3115080C2 (fr)
DK (1) DK173081A (fr)
ES (1) ES8207184A1 (fr)
FR (1) FR2480603B1 (fr)
GB (1) GB2074445B (fr)
IN (1) IN156105B (fr)
IT (1) IT1207106B (fr)
NL (1) NL8101899A (fr)
SE (1) SE447449B (fr)
ZA (1) ZA812600B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
EP0114577A1 (fr) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. Composition pharmaceutique
IT1201474B (it) * 1985-10-01 1989-02-02 Vincenzo Zappia Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
EP0566135A1 (fr) * 1992-04-17 1993-10-20 Takeda Chemical Industries, Ltd. Composition transmucosale contenant un peptide et un dérivé de la cytidine
CA2213000A1 (fr) * 1995-03-06 1996-09-12 Interneuron Pharmaceuticals, Inc. Reduction de l'ampleur des infarctus par la citicoline
AU2005201251B2 (en) * 1995-03-06 2006-04-27 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU1640400A (en) * 1995-03-06 2000-04-20 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
WO2001068104A1 (fr) * 2000-03-16 2001-09-20 The Mclean Hospital Corporation Composes servant a traiter des troubles psychiatriques ou des troubles provoques par la consommation abusive de substances psychoactives
CA2517290A1 (fr) * 2003-02-26 2004-09-10 Kyowa Hakko Kogyo Co., Ltd. Agent de formation musculaire et agent de prevention et de soins en cas d'affaiblissement musculaire
US7737128B2 (en) * 2004-06-10 2010-06-15 The Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
EP1765364A4 (fr) * 2004-06-10 2010-09-22 Mclean Hospital Corp Pyrimidines, tels que cytidine, dans les traitements de patients souffrant de troubles bipolaires
WO2006020703A1 (fr) * 2004-08-11 2006-02-23 The Mclean Hospital Corporation Compose pour le traitement de la dependance, de la suppression et de l'usage de la marijuana
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1189549A (en) * 1967-12-18 1970-04-29 Takeda Chemical Industries Ltd A Method for Production of Cytidine (Deoxycytidine)-5'-Diphosphate Choline and Intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS4841555B1 (fr) * 1969-08-04 1973-12-07
JPS4886869A (fr) * 1972-02-23 1973-11-15

Also Published As

Publication number Publication date
ES502080A0 (es) 1982-09-01
IT8048454A0 (it) 1980-04-18
FR2480603B1 (fr) 1985-07-12
BE890796A (fr) 1982-02-15
ATA172081A (de) 1984-04-15
AT376366B (de) 1984-11-12
SE8102456L (sv) 1981-10-19
CH652026A5 (it) 1985-10-31
DK173081A (da) 1981-10-19
NL8101899A (nl) 1981-11-16
US4386077A (en) 1983-05-31
AU544469B2 (en) 1985-05-30
DE3115080C2 (de) 1986-10-16
ZA812600B (en) 1982-04-28
GB2074445B (en) 1983-09-07
FR2480603A1 (fr) 1981-10-23
AU6994581A (en) 1981-10-22
GB2074445A (en) 1981-11-04
DE3115080A1 (de) 1982-02-25
IN156105B (fr) 1985-05-18
IT1207106B (it) 1989-05-17
ES8207184A1 (es) 1982-09-01

Similar Documents

Publication Publication Date Title
US5225404A (en) Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
ES2477873T3 (es) Disolución acuosa de composición farmacéutica de 20(R)-ginsenósido Rg3 y procedimiento de la misma
EP0139286A2 (fr) Préparation à libération prolongée de longue durée
MXPA03003401A (es) Formulacion liposomica de mitoxantrona.
JPS6310686B2 (fr)
KR20190077476A (ko) 상글리페린 거대고리 유사체의 항암 화합물로서의 용도
US4386077A (en) Pharmaceutical composition for oral administration containing cytidine diphosphocholine
JP2001520656A (ja) 抗腫瘍剤としてのホルボールエステル類
JP2004517882A (ja) トリプトライドプロドラッグを使用する抗癌処置
KR100235893B1 (ko) 크레아틴 포스페이트를 함유하는 종양 치료용 조성물
PT91302B (pt) Processo para a preparacao de composicoes farmaceuticas contendo imidazo {2,1-a} isoquinolinas substituidas por 5-heteroarilo ou 5-arilo
CA2351273C (fr) Solution de tetrahydrate de n-¬o-(p-pivaloyloxybenzenesulfonylamino)benzoyl|glycinate de monosodium et drogue contenant ce produit
CA2416600A1 (fr) Preparation lyophilisee de tetrahydrate monosodique de n-¬o-(p-pivaloyloxybenzenesulfonylamino)benzoyl|glycine et procede permettant de produire cette preparation
JPH027575B2 (fr)
KR960015953B1 (ko) 피부에 축적하는 외용의 항바이러스성 약학적 조성물 및 그 제조방법
JP6549107B2 (ja) がんの処置のための、ｒｏ５５０３７８１、カペシタビン及びオキサリプラチンの組み合わせ
Kim et al. The influence of homologs of riboflavin on the growth of Walker rat carcinoma 256
US4942172A (en) Method of curing hepatic disease
JPS632926A (ja) 安定な、注射可能な制吐性組成物
HU210934B (en) Process to prepare medicaments against metastases
MX2007005591A (es) Sintesis de analogos de cardiolipina y usos de los mismos.
JPH0720860B2 (ja) 制癌剤
JPS6337767B2 (fr)
JPS632414B2 (fr)
RU2614234C2 (ru) Фармацевтическая композиция на основе 3-(4-Метилимидазол-1-ил)имидазо[1,2-b][1,2,4,5]тетразина в качестве противоопухолевого средства

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8102456-4

Effective date: 19910117

Format of ref document f/p: F